391 related articles for article (PubMed ID: 19302906)
1. Impact of illegal trade on the quality of epoetin alfa in Thailand.
Fotiou F; Aravind S; Wang PP; Nerapusee O
Clin Ther; 2009 Feb; 31(2):336-46. PubMed ID: 19302906
[TBL] [Abstract][Full Text] [Related]
2. Optimization and qualification of capillary zone electrophoresis method for glycoprotein isoform distribution of erythropoietin for quality control laboratory.
Zhang J; Chakraborty U; Villalobos AP; Brown JM; Foley JP
J Pharm Biomed Anal; 2009 Oct; 50(3):538-43. PubMed ID: 19515523
[TBL] [Abstract][Full Text] [Related]
3. Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks.
Naughton CA; Duppong LM; Forbes KD; Sehgal I
Am J Health Syst Pharm; 2003 Mar; 60(5):464-8. PubMed ID: 12635452
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
5. Reduced drug costs from switching hemodialysis patients from epoetin alfa in multidose vials to pre-filled syringes.
Wazny LD; Raymond CB; Do MK; Skwarchuk DE
CANNT J; 2009; 19(3):39-41. PubMed ID: 19899498
[TBL] [Abstract][Full Text] [Related]
6. [Pure red blood cell aplasia associated with neutralizing antibodies against erythropoietin induced by epoetin alfa:a new form of acquired erythroblastopenia in auremic patients].
Cases A; Esforzado N; Mas M; Ricart MJ; Cruzado JM
Nefrologia; 2003; 23(3):266-70. PubMed ID: 12891943
[TBL] [Abstract][Full Text] [Related]
7. Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacteriostatic diluent.
Corbo DC; Suddith RL; Sharma B; Naso RB
Am J Hosp Pharm; 1992 Jun; 49(6):1455-8. PubMed ID: 1529989
[TBL] [Abstract][Full Text] [Related]
8. Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.
Seidl A; Hainzl O; Richter M; Fischer R; Böhm S; Deutel B; Hartinger M; Windisch J; Casadevall N; London GM; Macdougall I
Pharm Res; 2012 Jun; 29(6):1454-67. PubMed ID: 22094831
[TBL] [Abstract][Full Text] [Related]
9. Quality of amoxicillin formulations in some Arab countries.
Kyriacos S; Mroueh M; Chahine RP; Khouzam O
J Clin Pharm Ther; 2008 Aug; 33(4):375-9. PubMed ID: 18613855
[TBL] [Abstract][Full Text] [Related]
10. Epoetin-associated pure red cell aplasia: past, present, and future considerations.
McKoy JM; Stonecash RE; Cournoyer D; Rossert J; Nissenson AR; Raisch DW; Casadevall N; Bennett CL
Transfusion; 2008 Aug; 48(8):1754-62. PubMed ID: 18482185
[TBL] [Abstract][Full Text] [Related]
11. Biochemical assessment of erythropoietin products from Asia versus US Epoetin alfa manufactured by Amgen.
Park SS; Park J; Ko J; Chen L; Meriage D; Crouse-Zeineddini J; Wong W; Kerwin BA
J Pharm Sci; 2009 May; 98(5):1688-99. PubMed ID: 18781649
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
Rossert J;
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
[TBL] [Abstract][Full Text] [Related]
13. Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery.
Boven K; Knight J; Bader F; Rossert J; Eckardt KU; Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii33-40. PubMed ID: 15824129
[TBL] [Abstract][Full Text] [Related]
14. Epoetin alfa (Eprex): reports of pure red blood cell aplasia.
Wooltorton E
CMAJ; 2002 Feb; 166(4):480. PubMed ID: 11873930
[No Abstract] [Full Text] [Related]
15. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
Chan A; Lim LL; Tao M
Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
Macdougall IC
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv9-15. PubMed ID: 15827058
[TBL] [Abstract][Full Text] [Related]
17. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam.
Kachur SP; Black C; Abdulla S; Goodman C
Malar J; 2006 Mar; 5():25. PubMed ID: 16569252
[TBL] [Abstract][Full Text] [Related]
18. Eprex-associated pure red cell aplasia and leachates.
Schellekens H; Jiskoot W
Nat Biotechnol; 2006 Jun; 24(6):613-4. PubMed ID: 16763579
[No Abstract] [Full Text] [Related]
19. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
[TBL] [Abstract][Full Text] [Related]
20. Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.
Hermeling S; Jiskoot W; Crommelin DJ; Schellekens H
Pharm Res; 2006 Mar; 23(3):641-2; author reply 643-4. PubMed ID: 16525860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
